Cancer & Chronic Disease is categorized under Health Screening Services in El Paso, TX and active since 1991.
Cancer & Chronic Disease was established in 1991, and today employs 1 to 4, earning Unknown per year. This is a Health Screening Services business, which does work in the B2C market, and is classified as a Health Screening Services, under code number 8133190 by the NAICS.
If you are seeking more information, feel free to contact Pat Morales, Executive Director at the company’s single location by writing to 6070 Gateway Boulevard East # 310, El Paso, Texas TX 79905 or by phoning (915) 771-6305. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer & Chronic Disease |
| Contact Person: | Pat Morales, Executive Director |
| Address: | 6070 Gateway Boulevard East # 310, El Paso, Texas 79905 |
| Phone Number: | (915) 771-6305 |
| Annual Revenue (USD): | Unknown |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Screening Services |
| SIC Code: | 8099 |
| NAICS Code: | 8133190 |
| Share This Business: |
Cancer & Chronic Disease was started in 1991 to provide professional Health Screening Services under the SIC code 8099 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Pat Morales, Executive Director for inquiries that concern Cancer & Chronic Disease by calling the company number (915) 771-6305, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer & Chronic Disease can be found at the coordinates 31.781204,-106.41136 as well as the street address 6070 Gateway Boulevard East # 310 in El Paso, Texas 79905.
For its online presence, you may visit Cancer & Chronic Disease’s website at and engage with its social media outlets through on Twitter and on Facebook.